In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
John P. Veluchamy(Cancer Center Amsterdam), Daniëlle A.M. Heideman(University Medical Center Groningen), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Silvia Lopez‐Lastra(Inserm), Fenna Bohme(AIMM Therapeutics (Netherlands)), Henk M.W. Verheul(Erasmus MC Cancer Institute), James P. Di Santo(Inserm), Tanja D. de Gruijl(Dutch Cancer Society), Nina Kok(AIMM Therapeutics (Netherlands))
Cited by 49
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|582
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554